1 More direct studies on the effect of altering dietary calcium in spontaneously hypertensive rats (SHR) have shown that the typical increase in systolic blood pressure that occurs with age is accelerated by low calcium diets and attenuated by high calcium diets. It is of importance, however, that serum total and ionized calcium levels in these animals were minimally affected by high calcium diet.
studies, dietary supplements of calcium have been reported to reduce blood pressure in humans. 3 ' * Resnick et al. 3 6 have shown that such a reduction in blood pressure in hypertensive humans is inversely related to initial serum calcium and plasma renin activity levels.
There is also evidence that the calcium ion itself promotes hypertension. Substances that prevent the entry of calcium into cells have been reported to reduce blood pressure in hypertensive humans, 7 and calcium is required in the external medium for the action of vasoconstrictors such as norepinephrine and vasopressin. 8> 9 Our preliminary studies with mongrel dogs have shown that intravenous calcium chloride infusions, which resulted in hypercalcemia, caused an increase in peripheral resistance and a decrease in serum magnesium levels. 10 We undertook the present study using mongrel dogs to gain more insight into the effect of dietary calcium on blood pressure. Systemic and renal hemodynamics and water and electrolyte excretion were investigated after chronic hypercalcemia was induced by a dietary supplement of calcium and vitamin D.
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Materials and Methods
All animal studies were performed in accordance with the guidelines of the Veterans Administration Research Committee of the Royal C. Johnson VA Medical Center, Sioux Falls, South Dakota.
Protocol
Twenty female mongrel dogs weighing between 14 and 25 kg were fed commercial dog chow (Purina, St. Louis, MO, USA) and water ad libitum. In 10 of these dogs, designated as experimental animals, hypercalcemia was induced by giving them daily oral doses of calcium gluconate, 100 mg/kg, and vitamin D, 10,000 U/kg, for 2 weeks. The remaining 10 dogs, designated as control animals, did not receive the calcium and vitamin D.
The animals were anesthetized with sodium pentobarbital (Nembutal), 30 mg/kg body weight, before surgical placement and externalization of catheters in the right femoral artery and vein and placement of a thermodilution catheter in the pulmonary artery through the right jugular vein. During the operation each animal was ventilated using a Harvard pump respirator (Millis, MA, USA) set for 300-ml strokes at a rate of 12 strokes/min and received 200 to 300 ml of 0.9% NaCl by intravenous drip. After the operation each animal was given 600,000 units of procaine penicillin G intramuscularly and allowed to recover overnight.
The next day, the animal was placed in a sling, which supported it in the standing position, and an 8F Foley catheter (Bard, Murray Hill, NJ, USA) was inserted into the bladder. Baseline measures of blood pressures, cardiac output (CO), and cardiac index (CI) were made. Blood was drawn from one of the femoral catheters for later determination of plasma renin activity, plasma aldosterone concentration, whole blood ionized calcium (iCa), ionized potassium, ionized sodium, total serum calcium, and serum magnesium (sMg).
An infusion of a bolus dose of inulin (50 mg/kg) and /j-aminohippuric acid (PAH), 20 mg/kg, in 50 ml of 0.9% NaCl then was initiated at a rate of 3.3 ml/min and was followed by a maintenance dose of inulin (20 mg/min) and PAH (5 mg/min) in 125 ml of 0.9% NaCl administered at a rate of 0.44 ml/min. Both doses were infused into the catheter in the femoral vein. One hour was allowed for equilibration, and then a graduated cylinder was attached to the end of the Foley catheter for urine collection. Thirty minutes later, blood was drawn for determination of plasma renin activity, plasma aldosterone, iCa, ionized potassium and sodium, serum calcium, sMg, and plasma inulin and PAH concentrations. Blood pressures, CO, and CI were also measured at this time. The urine volume for the first hour was recorded, and the urine was frozen for subsequent determination of urine osmolarity; calcium, magnesium, sodium, potassium, and prostaglandin Ej (PGEj) concentrations; and calculation of electrolyte excretion rates. Two more such 1-hour urine collections followed; each time, blood pressures, CO, and CI were measured and blood samples were obtained halfway through the collection period.
Measurements
Systolic blood pressure, diastolic blood pressure, and mean arterial pressure in the femoral artery were determined using pressure transducers filled with 0.9% NaCl attached to a physiological recorder (Gould, Cleveland, OH, USA) that was calibrated periodically with a mercury manometer. The CO and CI were determined by thermodilution using a cardiac index computer (Gould, Cleveland, OH, USA), which computes CO using a modified form of the StewartHamilton indicator dilution equation; 10 ml of room temperature 0.9% NaCl was used as the injectate. The computer monitors the change in blood temperature over time and uses this value as well as the volume and temperature of injectate to determine CO and gives a digital readout. The CI is calculated automatically by dividing the CO by the body surface area of the animal. Body surface area is calculated by the computer using the Dubois height-weight equation. Digital readouts of both CI and body surface area are given by the computer.
Stroke volume was calculated by dividing the CO for a given period by the heart rate for that period. Total peripheral resistance (TPR) was calculated by dividing the mean arterial pressure for a given recording period by the corresponding CO. Renal resistance was calculated by dividing the mean arterial pressure for a given recording period by the renal blood flow for that period. Ionized calcium, sodium, and potassium, and urinary excretion of potassium and sodium were determined using ion-selective electrodes with a Nova 6 electrolyte analyzer (Nova Biomedical, Newton, MA, USA). Serum calcium, urinary calcium excretion, blood urea nitrogen, and plasma creatinine were determined colorimetrically with an American Monitor KDA analyzer (Indianapolis, IN, USA). Serum magnesium and urinary magnesium excretion were determined colorimetrically using a Dupont ACA analyzer (Wilmington, DE, USA).
Plasma renin activity and plasma aldosterone level were measured as described previously by our group.'' Plasma renin activity was calculated as the amount of angiotensin I generated in a maleate buffer for 90 minutes, which was determined by competition with 125 Iangiotensin for binding to antibody-coated tubes.
To obtain the urinary PGEj concentration, 1-ml urine samples were acidified to a pH of 3 with formic acid. Then 10 ml of chloroform was added, and the mixture was centrifuged. The upper (nonpolar) layer was aspirated, and the chloroform then was removed by nitrogen evaporation at 37 °C, leaving the PGEâ dhered to the walls of the tube. The PGEj was then reconstituted with 1 ml of gelatin-phosphate buffer, and the PGEj concentration was determined by radioimmunoassay as described previously by our group. 12 The PGEj in an aliquot of the extracted and purified experimental sample competes with added tritium-labeled PGEj (pHlPGF^) for binding with the antibody (Sigma, St. Louis, MO, USA). Separation of bound from free PGEj is accomplished by adding a cold dextran charcoal solution, followed by centrifugation. Supernatant scintillation counts are interpreted from a standard curve generated from scintillation counts of standard samples in which pHJPGF^ is displaced from the antibody by the addition of known quantities of cold (non-tritium-labeled) PGE^. There was less than 26% variation of results in 40 replicate measurements of a control sample. Osmolarity was determined using a Fiske Osmaticautomatic Osmometer (Uxbridge, MA, USA). Inulin and PAH concentrations in plasma and urine and glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined as previously described by our group. 13 Inulin concentrations in urine and plasma samples were determined by the anthrone colorimetric method. The PAH concentration also was determined by a spectrophotometric method. Both of these are standard methods for measuring inulin and PAH clearances. Renal blood flow was calculated from the formula renal blood flow = ERPF/(1 -hematocrit).
Fractional excretion was calculated by the following formula: fractional excretion = UV I /GFR-/ J I , where UV, is the excretion rate of x and P x is the plasma concentration of x. Fractional excretion of water was calculated from the formula fractional excretion of water = 1 divided by UIP inulin. Hematocrit was determined with a Coulter S Plus analyzer (Hialeah, FL, USA).
Statistical Analysis
The values reported for each dog are the average of the baseline and three ensuing recording periods. In the case of the urine parameters the values reported are the average of the three results from the separate urine collections. Statistical analysis was by the MannWhitney U test. Parameters designated significant in the text are those in which the Mann-Whitney test showed significance with 95% or greater confidence. Coefficients of correlation were calculated by regression analysis. Significant results are again set at 95% or greater confidence limits. Figures 1 and 2 , heart rate and TPR were significantly higher in the experimental group (p< 0.025 and p<0.05, respectively) and systolic blood pressure was significantly lower (/?<0.05). Diastolic blood pressure, mean arterial pressure, CO, and CI were not significantly different in the two groups. Stroke volume was significantly lower in the hypercalcemic animals (0.024 ± 0.006 vs 0.036 ±0.008 L/beat; p<0.005; data not shown). Figures 3 and 4 show the mean results obtained by various analyses of blood. Total serum calcium, iCa, and serum creatinine were significantly higher (p<0.0005 for each) and sMg was significantly lower (p< 0.0005) in the experimental group. Whole blood ionized potassium, whole blood ionized sodium, plasma renin activity, plasma aldosterone, blood urea nitrogen, and hematocrit were not significantly different in the two groups. Figures 5 and 6 show the means of various measures of renal function in the two groups. The hypercalcemic group had a significantly lower GFR, ERPF, renal blood flow, and osmolarity (/>< 0.005 in all cases). Renal resistance was also calculated but is not shown in the figures. At 0.57 ± 0.07 mm Hg/ml/min in the experimental group versus 0.28 ± 0.01 mm Hg/ml/min in the control group, it was significantly higher (p<0.005) in the experimental group. Potassium excretion rate was also significantly lower (p< 0.025) and urinary calcium excretion was significantly higher (p<0.05) in the experimental group. Urinary sodium and magnesium excretion rates were not significantly different in the two groups. Figure 7 gives the mean fractional excretion rates for water and electrolytes in the two groups. Fractional excretion of sodium (p<0.005), calcium (p<0.0l), magnesium (p<0.005), and water (p<0.005) were all significantly higher in the experimental group, as was urine flow rate (p<0.05). Fractional excretion of potassium and urinary PGEj excretion were not different in the two groups.
Results

Figures 1 dirough 7 illustrate the mean values of the various measurements for each group. As shown in
Correlation coefficients were calculated to determine the relation between different factors that may have been affected by high dietary calcium and vitamin D. These are given in Table 1 . Ionized calcium showed significant positive correlations with serum calcium (p<0.001), renal resistance (p<0.05), heart rate (/?<0.05), and fractional excretion of sodium (p<0.01), calcium (p<0.00l), magnesium (/><0.001), and water (p<0.001) and significant negative correlations with sMg (/?<0.05), stroke volume (p<0.01), renal blood flow (/?<0.01), GFR (p<0.001), ERPF (/?<0.01), and osmolarity (p<0.01). Serum magnesium showed significant negative correlations with serum calcium (/?<0.05), iCa (p<0.05), diastolic blood pressure (p<0.05), heart rate (p<0.05), urine flow rate (p<0.05), and fractional excretion of water (p<0.05).
Discussion
The effect of dietary supplementation with calcium and vitamin D on systemic and renal hemodynamics in conscious dogs was studied. The experimental animals had a greater urine flow rate and higher fractional excretion of water, sodium, magnesium, and calcium. Increased calcium plus vitamin D therefore seems to have a diuretic effect, which acts to decrease blood volume and thereby blood pressure. Evidence for a lower blood volume in the experimental animals is a by guest on July 15, 2017 iCa = whole blood ionized calcium; MAP = mean arterial pressure; TPR = total peripheral resistance; PRA = plasma renin activity; ANG I = angiotensin I; UPGE2 = urinary prostaglandin E2 excretion; UFR = urine flow rate; GFR = glomerular filtration rate; ERPF = effective renal plasma flow.
*p< 0.05, significant correlation.
tion are linked, perhaps to the increased sodium excretion. Aldosterone levels, plasma renin activity, and urinary PGE, were unaffected. Despite the increased fractional excretion of electrolytes, urine osmolarity was much lower in the experimental group. This impairment of renal concentrating ability has previously been noted in hypercalcemia and seems mainly due to decreased reabsorption of sodium in the loop of Henle. 23 '* The role of parathyroid hormone (PTH) and the sympathetic nervous system in the vascular changes caused by chronic hypercalcemia resulting from increased dietary calcium and vitamin D must also be considered. We did not measure changes in PTH levels in the animals made chronically hypercalcemic by dietary calcium and vitamin D supplementation. As acute administration of PTH is vasodilative, 27 it may contribute to changes in vascular resistance produced by altering calcium levels. In our previous studies in dogs, however, we have shown little contribution of changes in PTH to elevated vascular resistances seen during hypercalcemia. 28 Rather, PTH participates more in reduced vascular resistances during hypocalcemia. 28 Anderson et al. 27 found conversely that a high calcium diet in SHR led to greater sensitivity and prolonged response to vasodilator effects of PTH infusion. Difference in species may be important, as Mulvaney et al. 29 suggests that vascular responses of SHR are unique because of an intrinsic defect of their vascular smooth muscle.
The chronic effect of PTH on blood pressure seems to be different than that of the acute effect. Parathyroidectomy slows the development of hypertension in SHR and deoxycorticosterone acetate and salt-treated rats independently of the calcium level. 30 ' 31 Long-term PTH administration would seem to potentiate the effects of increased vascular resistance in hypercalcemia since it may act as a calcium ionophore. 32 During calcium and vitamin D administration as produced in this study, PTH would be suppressed and would be unlikely to play a role in the increased vascular resistance. Suppressed PTH levels could explain in part why our model of hypercalcemia does not produce hypertension while chronic hyperparathyroid hypercalcemia does. Another difference may be that hyperparathyroidism often produces milder elevations of blood calcium 33 than those produced in this study. We also did not measure catecholamine levels in this study. Vlachakis et al. 34 and others have clearly shown that hypercalcemia does elevate catecholamine levels, which can result in increased vascular resistance.
In conclusion, increased dietary calcium and vitamin D leading to increased iCa in the blood appear to result in increased diuresis and decreased blood volume, which act to decrease blood pressure. This decrease was evidenced by a lower systolic blood pressure in the experimental group. Increased iCa also led to decreased serum magnesium, while TPR was increased. These results resolve some of the conflict over the effect of dietary calcium on blood pressure -a diuretic effect of increased blood calcium does act to decrease blood pressure, but this decrease is opposed by an increase in TPR. We conclude that this increase in TPR is related to increased blood iCa, a lowered serum magnesium level, or an interaction between the two.
